BSN CAPITAL PARTNERS Ltd raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 519.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 171,000 shares of the medical equipment provider’s stock after acquiring an additional 143,376 shares during the quarter. Intuitive Surgical comprises 4.1% of BSN CAPITAL PARTNERS Ltd’s investment portfolio, making the stock its 9th biggest holding. BSN CAPITAL PARTNERS Ltd’s holdings in Intuitive Surgical were worth $91,928,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Holos Integrated Wealth LLC bought a new position in Intuitive Surgical during the fourth quarter worth $25,000. Newbridge Financial Services Group Inc. raised its position in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares during the last quarter. Olistico Wealth LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. Caitlin John LLC purchased a new stake in Intuitive Surgical in the 3rd quarter worth about $30,000. Finally, Laurel Wealth Advisors LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $31,000. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Stock Performance
ISRG stock opened at $406.78 on Friday. The stock has a market cap of $144.07 billion, a PE ratio of 49.31, a P/E/G ratio of 3.31 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $396.68 and a 12 month high of $603.88. The company has a 50-day moving average price of $438.43 and a 200 day moving average price of $490.46.
Insider Buying and Selling at Intuitive Surgical
In related news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the sale, the director owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,169 shares of company stock valued at $3,059,135 over the last ninety days. Corporate insiders own 0.60% of the company’s stock.
Analyst Ratings Changes
Several research analysts recently weighed in on ISRG shares. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. BTIG Research reiterated a “buy” rating and set a $574.00 target price on shares of Intuitive Surgical in a report on Wednesday, April 22nd. The Goldman Sachs Group set a $558.00 price target on Intuitive Surgical in a report on Wednesday, May 27th. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Finally, Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a research report on Wednesday, March 11th. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $573.42.
Check Out Our Latest Analysis on ISRG
Intuitive Surgical Profile
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Read More
- Five stocks we like better than Intuitive Surgical
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
